Atrial Fibrillation and Heart Failure: Diagnosis, Risk Stratification, and Clinical Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 20 December 2026 | Viewed by 113
Special Issue Editor
Interests: cardiac electrophysiology; cardiac resynchronisation therapy; left bundle area pacing; conduction system pacing; sudden cardiac death; lead extractions
Special Issue Information
Dear Colleagues,
Atrial fibrillation (AF) and heart failure (HF) frequently coexist and are associated with increased risks of hospitalization, stroke, and mortality. Their coexistence complicates clinical management, particularly in relation to rhythm versus rate control, anticoagulation, and the optimization of heart failure therapy.
This Special Issue focuses on clinically relevant aspects of AF and HF, including diagnosis and phenotyping, risk stratification, and evidence-based management strategies. Topics of interest include anticoagulation in complex patients, integration of guideline-directed medical therapy, patient selection for catheter ablation, and management of acute and chronic HF in the presence of AF.
We welcome original clinical studies, real-world data analyses, and systematic reviews that provide actionable insights into patient management and clinical outcomes. Submissions addressing risk prediction, imaging, and biomarkers with direct clinical applicability are also encouraged.
Dr. Christian Grebmer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- heart failure
- clinical management
- risk stratification
- anticoagulation
- catheter ablation
- guide-line-directed therapy
- clinical outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
